SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software is trending due to a significant sell-off after its Q4 earnings beat was overshadowed by weaker-than-expected Q1 guidance and ongoing concerns about AI competition. The community is sharply divided between those fearing further downside from AI disruption and others viewing it as an oversold opportunity, highlighting the company's internal growth in areas like Vector ads and Unity 6 adoption.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as the community anticipates its upcoming earnings, with high expectations for updates on its oral VK2735 program and strong speculation surrounding its potential to advance directly to Phase 3 development. Investors are actively discussing the significant market opportunity in obesity, fueled by the recent regulatory crackdown on compounded GLP-1s, bolstering conviction in VKTX's "best-in-class" pipeline and increasing buyout or partnership speculation amidst Big Pharma's search for late-stage assets.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is experiencing a significant rally following an impressive earnings report, which highlighted record revenue, improved margins, and a strong pivot to profitability, with the community actively discussing its turnaround as a key player in edge computing security benefiting from AI adoption.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending amidst a short report questioning its flight test progress and certification timeline, sparking community debate over the report's credibility versus Archer's strategic partnerships with major companies and and significant institutional investments. Investors are keenly discussing the company's transparency and technical milestones, anticipating upcoming FAA eIPP selections as a potential catalyst.

GhostwareOS (GHOST) is the Full-Stack Privacy Layer of Solana — a next-generation AI-driven infrastructure for encrypted communication, anonymous identity management, and untraceable transactions. By combining advanced zero-knowledge protocols with autonomous AI routing, GhostwareOS allows users and developers to operate invisibly across Web3. It powers decentralized apps that demand true digital anonymity, scalable privacy, and zero metadata leakage — restoring control to users in an overexposed internet age.

Ghost

GHOST CRYPTO is trending strongly amid anticipation for new privacy features like GhostSend and a structured ecosystem participation model rolling out next week. The community is actively discussing its potential as Solana's default privacy layer, projecting significant growth and revenue sharing for holders.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin is trending upward as a prominent short-seller retracted their allegations of financial misconduct, fueling community discussion about market manipulation and heightened anticipation for the company's strong earnings report.

HubSpot, Inc. engages in cloud-based customer relationship management. Its platform includes marketing, sales, service, operations and content management system, as well as other tools, integrations and native payment solutions. It operates through the following geographical segments: Americas, Europe and Asia Pacific. The company was founded by Brian Patrick Halligan and Dharmesh Shah on April 4, 2005, and is headquartered in Cambridge, MA.

HubSpot Inc

HubSpot is trending after reporting strong earnings, raising guidance, and announcing a $1 billion share buyback. Despite the positive news, the stock saw a significant decline, sparking community debate over whether AI disruption fears are outweighing solid fundamentals in the broader software sector.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

Cardano is trending amidst intense debate, as founder Charles Hoskinson's vision for mainstream blockchain integration clashes with significant community frustration over its sustained price decline; however, a dedicated group maintains strong bullish conviction, anticipating a major rebound and actively accumulating at current levels.

Berachain

Berachain (BERA) is gaining attention for recent protocol upgrades and its unique Proof-of-Liquidity model, alongside new reward vaults and integrations that are growing its Total Value Locked. The community is actively discussing its potential as a leading L1 DeFi player, though some express caution regarding past price performance and token dynamics.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is trending as it navigates complex FDA feedback on its Huntington's disease gene therapy, AMT-130, with a scheduled Type A meeting to discuss its Biologics License Application data package for accelerated approval, fueling community speculation on regulatory outcomes and potential acquisition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy

ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance...

MeiraGTx Holdings PLC (NASDAQ:MGTX) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of MeiraGTx Holdings PLC (NASDAQ:MGTX - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the six analysts that are currently covering the firm, Marketbeat.com...

MeiraGTx Holdings PLC (NASDAQ:MGTX) Given Average Rating of "Moderate Buy" by Analysts

MeiraGTx Holdings PLC (NASDAQ:MGTX - Get Free Report) has been assigned an average rating of "Moderate Buy" from the six research firms that are currently covering the stock, MarketBeat reports. One...

MeiraGTx (NASDAQ:MGTX) Stock Price Up 6.9% - What's Next?

MeiraGTx (NASDAQ:MGTX) Trading 6.9% Higher - Still a Buy...

MeiraGTx (NASDAQ:MGTX) Trading Up 7.6% - What's Next?

MeiraGTx (NASDAQ:MGTX) Shares Up 7.6% - Here's Why...

683 Capital Management LLC Boosts Stock Holdings in MeiraGTx Holdings PLC $MGTX

683 Capital Management LLC grew its holdings in MeiraGTx Holdings PLC (NASDAQ:MGTX - Free Report) by 4.5% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The...

586,519 Shares in MeiraGTx Holdings PLC $MGTX Acquired by 22NW LP

22NW LP acquired a new stake in shares of MeiraGTx Holdings PLC (NASDAQ:MGTX - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities...

MeiraGTx Holdings PLC (NASDAQ:MGTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

MeiraGTx Holdings PLC (NASDAQ:MGTX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the six ratings firms that are presently covering the company, MarketBeat Ratings...

MeiraGTx (NASDAQ:MGTX) Sees Strong Trading Volume - Here's Why

MeiraGTx (NASDAQ:MGTX) Sees Unusually-High Trading Volume - Here's Why...

Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx Conference

Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx Conference Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx...

MeiraGTx Holdings Plc is a clinical-stage genetic medicines company with a broad pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy. It targets local delivery of small doses of genetic medicines to treat both inherited and more common conditions with severe unmet needs. The company was founded on March 20, 2015 and is headquartered in New York, NY.

MeiraGTx Holdings plc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $COIN earnings on Thursday?

Current Price	$7.46
Prev Close	$7.52
Open	$7.53
Dividend Yield	0.00%
50-Day Moving Average	$7.93
Beta	1.38
Avg. Volume	426,770.15
PE Ratio	-3.56

52-Week High	$9.73
52-Week Low	$4.55
Market Capitalization	$605.29M
EPS (Annual)	-$2.12
Price to Book	-14.92
Revenue Per Employee	$87,346.46

MGTX
MeiraGTx Holdings plc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MGTX News

MGTXMeiraGTx Holdings plc